Genecast was established in Beijing in 2014 and is headquartered in the city of Wuxi, Jiangsu Province. It boasts a total of more than 7000㎡ in operating space, with facilities in cities such as Beijing and Taizhou. This includes its CAP-certified precision medicine diagnostic laboratory, which holds a Practice License of Medical Institution, awarded by Wuxi City Health Commission; its precision tumor diagnosis and treatment big data center; and its GMP-compliant IVD reagents manufacturing base.
We Provide Precision Testings and Diagnostics Certified By Multiple International Professional Organizations.
Genecast is a State high-tech enterprise, which holds the National Center for Clinical Laboratories (NCCL) certificate for successful technical acceptance of clinical gene amplification testing laboratories. It has been formally licensed to engage in “tumor-related gene testing items (conventional ARMS method and NGS method).”
The company’s work centers on second-generation sequencing technology and bioinformatics, and it is committed to providing the most professional decision-making services on genetic testing-based precision tumor diagnosis and treatment for companies engaged in tumor diagnosis and treatment. Finally, through its application of genetic testing and real-world clinical data to connect pharmaceutical companies, doctors and patients, it realizes its vision of being “committed to innovating technology, improving human health, and achieving the future of medicine.”
With the second-generation sequencing technology and bioinformatics as the core, we are engaged in
non-invasive precision diagnosis and accompanying diagnosis of tumors, and provide individualized health guidance for patients.
It has regional marketing and service branches in 28 major provinces across China, covering nearly 500 Tier-A hospitals. Cooperation programs are also being carried out with over 20 well-known domestic and foreign pharmaceutical companies.
Genecast Accompanied Every step of our calculations.